FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval

[FDA]

The FDA converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.


Baca selengkapnya di : http://www.fda.gov...